AGER -429T/C Is Associated with an Increased Lung Disease Severity in Cystic Fibrosis

• Julie Beucher,

  Affiliations AP-HP, Hôpital Trousseau, Pediatric Pulmonary Department, Inserm U938, Paris, France, CHU de Rennes, Hôpital Sud, Rennes, France, Université Pierre et Marie Curie-Paris 6, Paris, France

  ⨯
• Pierre-Yves Boëlle,

  Affiliations Université Pierre et Marie Curie-Paris 6, Paris, France, AP-HP, Hôpital St Antoine, Biostatistics Department, Inserm UMR-S707, Paris, France

  ⨯
• Pierre-François Busson,

  Affiliation AP-HP, Hôpital St Antoine, Biostatistics Department, Inserm UMR-S707, Paris, France

  ⨯
• Céline Muselet-Charlier,

  Affiliation AP-HP, Hôpital Trousseau, Pediatric Pulmonary Department, Inserm U938, Paris, France

  ⨯
• Annick Clement,

  Affiliations AP-HP, Hôpital Trousseau, Pediatric Pulmonary Department, Inserm U938, Paris, France, Université Pierre et Marie Curie-Paris 6, Paris, France

  ⨯
• Harriet Corvol, on behalf of the French C F Modifier Gene Study Investigators

  * E-mail: harriet.corvol@trs.aphp.fr

  Affiliations AP-HP, Hôpital Trousseau, Pediatric Pulmonary Department, Inserm U938, Paris, France, Université Pierre et Marie Curie-Paris 6, Paris, France

  ⨯